127 related articles for article (PubMed ID: 23839087)
1. Polymorphic variation of CYP1A1 and CYP1B1 genes in a Haryana population.
Giri SK; Yadav A; Kumar A; Dev K; Gulati S; Gupta R; Aggarwal N; Gautam SK
Biochem Genet; 2013 Dec; 51(11-12):853-64. PubMed ID: 23839087
[TBL] [Abstract][Full Text] [Related]
2. CYP1A1 and CYP3A4 polymorphic variations in Delhi population of Northern India.
Kumar V; Singh S; Yadav CS; Ahmed RS; Gupta S; Pasha ST; Tripathi AK; Banerjee BD
Environ Toxicol Pharmacol; 2010 Mar; 29(2):126-30. PubMed ID: 21787593
[TBL] [Abstract][Full Text] [Related]
3. Frequency Evaluation of T6235C (m1) and A4889G (m2) Polymorphisms of CYP1A1 Gene in a Healthy Population from the west of Mazandaran Province, Iran.
Ahangar N; Alizadeh B; Tousi A
Cell Mol Biol (Noisy-le-grand); 2016 Jun; 62(7):90-6. PubMed ID: 27453279
[TBL] [Abstract][Full Text] [Related]
4. Case-control study of ovarian cancer and polymorphisms in genes involved in catecholestrogen formation and metabolism.
Goodman MT; McDuffie K; Kolonel LN; Terada K; Donlon TA; Wilkens LR; Guo C; Le Marchand L
Cancer Epidemiol Biomarkers Prev; 2001 Mar; 10(3):209-16. PubMed ID: 11303589
[TBL] [Abstract][Full Text] [Related]
5. Polymorphisms of cytochrome P450 1A1, glutathione S-transferases M1 and T1 in a Turkish population.
Ada AO; Süzen SH; Iscan M
Toxicol Lett; 2004 Jun; 151(1):311-5. PubMed ID: 15177667
[TBL] [Abstract][Full Text] [Related]
6. A study on the association of cytochrome-P450 1A1 polymorphism and breast cancer risk in north Indian women.
Singh V; Rastogi N; Sinha A; Kumar A; Mathur N; Singh MP
Breast Cancer Res Treat; 2007 Jan; 101(1):73-81. PubMed ID: 16807674
[TBL] [Abstract][Full Text] [Related]
7. Ah receptor, CYP1A1, CYP1A2 and CYP1B1 gene polymorphisms are not involved in the risk of recurrent pregnancy loss.
Saijo Y; Sata F; Yamada H; Suzuki K; Sasaki S; Kondo T; Gong YY; Kato EH; Shimada S; Morikawa M; Minakami H; Kishi R
Mol Hum Reprod; 2004 Oct; 10(10):729-33. PubMed ID: 15299091
[TBL] [Abstract][Full Text] [Related]
8. Candidate genetic modifiers of individual susceptibility to renal cell carcinoma: a study of polymorphic human xenobiotic-metabolizing enzymes.
Longuemaux S; Deloménie C; Gallou C; Méjean A; Vincent-Viry M; Bouvier R; Droz D; Krishnamoorthy R; Galteau MM; Junien C; Béroud C; Dupret JM
Cancer Res; 1999 Jun; 59(12):2903-8. PubMed ID: 10383153
[TBL] [Abstract][Full Text] [Related]
9. Genetic polymorphisms of cytochrome P450 CYP1A1 (*2A) and microsomal epoxide hydrolase gene, interactions with tobacco-users, and susceptibility to bladder cancer: a study from North India.
Srivastava DS; Mandhani A; Mittal RD
Arch Toxicol; 2008 Sep; 82(9):633-9. PubMed ID: 18200441
[TBL] [Abstract][Full Text] [Related]
10. Is genetic polymorphism of ER-α, CYP1A1, and CYP1B1 a risk factor for uterine leiomyoma?
El-Shennawy GA; Elbialy AA; Isamil AE; El Behery MM
Arch Gynecol Obstet; 2011 Jun; 283(6):1313-8. PubMed ID: 20559649
[TBL] [Abstract][Full Text] [Related]
11. Polymorphisms in genes involved in sex hormone metabolism, estrogen plus progestin hormone therapy use, and risk of postmenopausal breast cancer.
Diergaarde B; Potter JD; Jupe ER; Manjeshwar S; Shimasaki CD; Pugh TW; Defreese DC; Gramling BA; Evans I; White E
Cancer Epidemiol Biomarkers Prev; 2008 Jul; 17(7):1751-9. PubMed ID: 18628428
[TBL] [Abstract][Full Text] [Related]
12. Genetic polymorphisms in CYP1A1, CYP1B1, COMT, GSTP1 and NAT2 genes and association with bladder cancer risk in a French cohort.
Fontana L; Delort L; Joumard L; Rabiau N; Bosviel R; Satih S; Guy L; Boiteux JP; Bignon YJ; Chamoux A; Bernard-Gallon DJ
Anticancer Res; 2009 May; 29(5):1631-5. PubMed ID: 19443378
[TBL] [Abstract][Full Text] [Related]
13. Relationship between genetic polymorphisms of drug-metabolizing enzymes (CYP1A1, CYP2E1, GSTM1, and NAT2), drinking habits, histological subtypes, and p53 gene point mutations in Japanese patients with gastric cancer.
Suzuki S; Muroishi Y; Nakanishi I; Oda Y
J Gastroenterol; 2004; 39(3):220-30. PubMed ID: 15064998
[TBL] [Abstract][Full Text] [Related]
14. Role of xenobiotic metabolizing gene polymorphisms in breast cancer susceptibility and treatment outcome.
Chacko P; Joseph T; Mathew BS; Rajan B; Pillai MR
Mutat Res; 2005 Mar; 581(1-2):153-63. PubMed ID: 15725614
[TBL] [Abstract][Full Text] [Related]
15. Cytochrome 1A1 and 1B1 gene diversity in the Zanzibar islands.
Cavaco I; Piedade R; Msellem MI; Bjorkman A; Gil JP
Trop Med Int Health; 2012 Jul; 17(7):854-7. PubMed ID: 22594779
[TBL] [Abstract][Full Text] [Related]
16. Association of functionally important polymorphisms in cytochrome P4501B1 with lung cancer.
Shah PP; Singh AP; Singh M; Mathur N; Mishra BN; Pant MC; Parmar D
Mutat Res; 2008 Aug; 643(1-2):4-10. PubMed ID: 18573508
[TBL] [Abstract][Full Text] [Related]
17. Allele and genotype frequencies of the polymorphic cytochrome P450 genes (CYP1A1, CYP3A4, CYP3A5, CYP2C9 and CYP2C19) in the Jordanian population.
Yousef AM; Bulatova NR; Newman W; Hakooz N; Ismail S; Qusa H; Zahran F; Anwar Ababneh N; Hasan F; Zaloom I; Khayat G; Al-Zmili R; Naffa R; Al-Diab O
Mol Biol Rep; 2012 Oct; 39(10):9423-33. PubMed ID: 22722998
[TBL] [Abstract][Full Text] [Related]
18. [Polymorphisms in detoxification genes CYP1A1, CYP2E1, GSTT1 and GSTM1 in gastric cancer susceptibility].
González A; Ramírez V; Cuenca P; Sierra R
Rev Biol Trop; 2004 Sep; 52(3):591-600. PubMed ID: 17361553
[TBL] [Abstract][Full Text] [Related]
19. Genetic factors in catechol estrogen metabolism in relation to the risk of endometrial cancer.
Doherty JA; Weiss NS; Freeman RJ; Dightman DA; Thornton PJ; Houck JR; Voigt LF; Rossing MA; Schwartz SM; Chen C
Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):357-66. PubMed ID: 15734958
[TBL] [Abstract][Full Text] [Related]
20. Induction of CYP1A1 and CYP1B1 and formation of carcinogen-DNA adducts in normal human mammary epithelial cells treated with benzo[a]pyrene.
Keshava C; Divi RL; Whipkey DL; Frye BL; McCanlies E; Kuo M; Poirier MC; Weston A
Cancer Lett; 2005 Apr; 221(2):213-24. PubMed ID: 15808407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]